Skip to main content
Erschienen in: Indian Journal of Gastroenterology 2/2017

10.04.2017 | Original Article

Quality of life of liver donors following donor hepatectomy

verfasst von: Biju Chandran, Viju Kumar Bharathan, Johns Shaji Mathew, Binoj Sivasankara Pillai Thankamony Amma, Unnikrishnan Gopalakrishnan, Dinesh Balakrishnan, Ramachandran Narayana Menon, Puneet Dhar, Sudheer Othiyil Vayoth, Sudhindran Surendran

Erschienen in: Indian Journal of Gastroenterology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Although morbidity following living liver donation is well characterized, there is sparse data regarding health-related quality of life (HRQOL) of donors.

Methods

HRQOL of 200 consecutive live liver donors from 2011–2014 performed at an Indian center were prospectively collected using the SF-36 version 2, 1 year after surgery. The effect of donor demographics, operative details, post-operative complications (Clavien-Dindo and 50-50 criteria), and recipient mortality on the quality-of-life (QOL) scoring was analyzed.

Results

Among 200 donors (female/male=141:59), 77 (38.5%) had complications (14.5%, 16.5%, 4.5%, and 3.5%, Clavien-Dindo grades I–IV, respectively). The physical composite score (PCS) of donors 1 year after surgery was less than ideal (48.75±9.5) while the mental composite score (MCS) was good (53.37±6.16). Recipient death was the only factor that showed a statistically significant correlation with both PCS (p<0.001) and MCS (p=0.05). Age above 50 years (p<0.001), increasing body mass index (BMI) (p=0.026), and hospital stay more than 14 days ( p= 0.042) negatively affected the physical scores while emergency surgery (p<0.001) resulted in lower mental scores. Gender, postoperative complications, type of graft, or fulfillment of 50-50 criteria did not influence HRQOL. On asking the hypothetical question whether the donors would be willing to donate again, 99% reiterated there will be no change in their decision.

Conclusion

Recipient death, donation in emergency setting, age above 50, higher BMI, and prolonged hospital stay are factors that lead to impaired HRQOL following live liver donation. Despite this, 99% donors did not repent the decision to donate.
Literatur
1.
Zurück zum Zitat Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002;346:1074–82.CrossRefPubMed Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med. 2002;346:1074–82.CrossRefPubMed
2.
4.
Zurück zum Zitat Takada Y, Suzukamo Y, Oike F, et al. Long-term quality of life of donors after living donor liver transplantation. Liver Transpl. 2012;18:1343–52.CrossRefPubMed Takada Y, Suzukamo Y, Oike F, et al. Long-term quality of life of donors after living donor liver transplantation. Liver Transpl. 2012;18:1343–52.CrossRefPubMed
5.
Zurück zum Zitat Cheah YL, Simpson MA, Pomposelli JJ, Pomfret EA. Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl. 2013;19:499–506.CrossRefPubMed Cheah YL, Simpson MA, Pomposelli JJ, Pomfret EA. Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl. 2013;19:499–506.CrossRefPubMed
6.
Zurück zum Zitat Middleton PF, Duffield M, Lynch SV, et al. Living donor liver transplantation—adult donor outcomes: a systematic review. Liver Transpl. 2006;12:24–30.CrossRefPubMed Middleton PF, Duffield M, Lynch SV, et al. Living donor liver transplantation—adult donor outcomes: a systematic review. Liver Transpl. 2006;12:24–30.CrossRefPubMed
8.
9.
Zurück zum Zitat Parikh ND, Ladner D, Abecassis M, Butt Z. Quality of life for donors after living donor liver transplantation: a review of the literature. Liver Transpl. 2010;16:1352–8.CrossRefPubMedPubMedCentral Parikh ND, Ladner D, Abecassis M, Butt Z. Quality of life for donors after living donor liver transplantation: a review of the literature. Liver Transpl. 2010;16:1352–8.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Erim Y, Beckmann M, Kroencke S, et al. Psychological strain in urgent indications for living donor liver transplantation. Liver Transpl. 2007;13:886–95.CrossRefPubMed Erim Y, Beckmann M, Kroencke S, et al. Psychological strain in urgent indications for living donor liver transplantation. Liver Transpl. 2007;13:886–95.CrossRefPubMed
12.
Zurück zum Zitat WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.CrossRef
13.
Zurück zum Zitat Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–83.CrossRefPubMed
14.
Zurück zum Zitat Qu B, Guo HQ, Liu J, Zhang Y, Sun G. Reliability and validity testing of the SF-36 questionnaire for the evaluation of the quality of life of Chinese urban construction workers. J Int Med Res. 2009;37:1184–90.CrossRefPubMed Qu B, Guo HQ, Liu J, Zhang Y, Sun G. Reliability and validity testing of the SF-36 questionnaire for the evaluation of the quality of life of Chinese urban construction workers. J Int Med Res. 2009;37:1184–90.CrossRefPubMed
15.
Zurück zum Zitat Simon GE, Revicki DA, Grothaus L, Vonkorff M. SF-36 summary scores: are physical and mental health truly distinct? Med Care. 1998;36:567–72.CrossRefPubMed Simon GE, Revicki DA, Grothaus L, Vonkorff M. SF-36 summary scores: are physical and mental health truly distinct? Med Care. 1998;36:567–72.CrossRefPubMed
16.
Zurück zum Zitat Nortvedt MW, Riise T, Myhr KM, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care. 2000;38:1022–8.CrossRefPubMed Nortvedt MW, Riise T, Myhr KM, Nyland HI. Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Med Care. 2000;38:1022–8.CrossRefPubMed
17.
Zurück zum Zitat Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res. 2001;10:395–404.CrossRefPubMed Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res. 2001;10:395–404.CrossRefPubMed
18.
Zurück zum Zitat Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001;10:405–13. discussion 15-20CrossRefPubMed Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001;10:405–13. discussion 15-20CrossRefPubMed
19.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8. discussion 8-9CrossRefPubMedPubMedCentral Balzan S, Belghiti J, Farges O, et al. The “50-50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824–8. discussion 8-9CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Jin SG, Xiang B, Yan LN, et al. Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol. 2012;18:182–7.CrossRefPubMedPubMedCentral Jin SG, Xiang B, Yan LN, et al. Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol. 2012;18:182–7.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Chan SC, Liu CL, Lo CM, Lam BK, Lee EW, Fan ST. Donor quality of life before and after adult-to-adult right liver live donor liver transplantation. Liver Transpl. 2006;12:1529–36.CrossRefPubMed Chan SC, Liu CL, Lo CM, Lam BK, Lee EW, Fan ST. Donor quality of life before and after adult-to-adult right liver live donor liver transplantation. Liver Transpl. 2006;12:1529–36.CrossRefPubMed
23.
Zurück zum Zitat Sinha R, van den Heuvel WJ, Arokiasamy P. Validity and reliability of MOS short form health survey (SF-36) for use in India. Indian J Community Med. 2013;38:22–6.CrossRefPubMedPubMedCentral Sinha R, van den Heuvel WJ, Arokiasamy P. Validity and reliability of MOS short form health survey (SF-36) for use in India. Indian J Community Med. 2013;38:22–6.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Fujita S, Kim ID, Uryuhara K, et al. Hepatic grafts from live donors: donor morbidity for 470 cases of live donation. Transpl Int. 2000;13:333–9.CrossRefPubMed Fujita S, Kim ID, Uryuhara K, et al. Hepatic grafts from live donors: donor morbidity for 470 cases of live donation. Transpl Int. 2000;13:333–9.CrossRefPubMed
25.
Zurück zum Zitat Brown Jr RS, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med. 2003;348:818–25.CrossRefPubMed Brown Jr RS, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med. 2003;348:818–25.CrossRefPubMed
26.
Zurück zum Zitat Fukunishi I, Sugawara Y, Makuuchi M, Surman OS. Pain in liver donors. Psychosomatics. 2003;44:172–3.CrossRefPubMed Fukunishi I, Sugawara Y, Makuuchi M, Surman OS. Pain in liver donors. Psychosomatics. 2003;44:172–3.CrossRefPubMed
27.
Zurück zum Zitat Trotter JF, Hill-Callahan MM, Gillespie BW, et al. Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation. 2007;83:1506–8.CrossRefPubMedPubMedCentral Trotter JF, Hill-Callahan MM, Gillespie BW, et al. Severe psychiatric problems in right hepatic lobe donors for living donor liver transplantation. Transplantation. 2007;83:1506–8.CrossRefPubMedPubMedCentral
Metadaten
Titel
Quality of life of liver donors following donor hepatectomy
verfasst von
Biju Chandran
Viju Kumar Bharathan
Johns Shaji Mathew
Binoj Sivasankara Pillai Thankamony Amma
Unnikrishnan Gopalakrishnan
Dinesh Balakrishnan
Ramachandran Narayana Menon
Puneet Dhar
Sudheer Othiyil Vayoth
Sudhindran Surendran
Publikationsdatum
10.04.2017
Verlag
Springer India
Erschienen in
Indian Journal of Gastroenterology / Ausgabe 2/2017
Print ISSN: 0254-8860
Elektronische ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-017-0743-7

Weitere Artikel der Ausgabe 2/2017

Indian Journal of Gastroenterology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.